-

AWS Introduces Graviton5—the Company’s Most Powerful and Efficient CPU

Fifth generation chip provides the best price performance for a broad range of workloads in Amazon EC2

LAS VEGAS--(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced Amazon EC2 M9g instances powered by the new Graviton5 chip.

Key takeaways

  • New AWS Graviton5-based Amazon EC2 M9g instances deliver up to 25% higher performance than the previous generation.
  • With 192 cores per chip and 5x larger cache, customers can scale up workloads and improve application performance while reducing infrastructure cost.
  • For the third year in a row, more than half of new CPU capacity added to AWS is powered by Graviton, and 98% of the top 1,000 EC2 customers, including Adobe, Airbnb, Atlassian, Epic Games, Formula 1, Pinterest, SAP, Siemens, Snowflake, and Synopsys, have already benefited from Graviton's price performance advantages.

To get the full story on Graviton5, visit About Amazon.

About AWS

Amazon Web Services (AWS) is guided by customer obsession, pace of innovation, commitment to operational excellence, and long-term thinking. By democratizing technology for nearly two decades and making cloud computing and generative AI accessible to organizations of every size and industry, AWS has built one of the fastest-growing enterprise technology businesses in history. Millions of customers trust AWS to accelerate innovation, transform their businesses, and shape the future. With the most comprehensive AI capabilities and global infrastructure footprint, AWS empowers builders to turn big ideas into reality. Learn more at aws.amazon.com and follow @AWSNewsroom.

Contacts

Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

Amazon.com, Inc.

NASDAQ:AMZN

Release Versions

Contacts

Amazon.com, Inc.
Media Hotline
Amazon-pr@amazon.com
www.amazon.com/pr

More News From Amazon.com, Inc.

Amazon Pharmacy Expands Access to Eli Lilly’s Zepbound KwikPen for Weight Management

SEATTLE--(BUSINESS WIRE)--Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that delivers medications quickly and directly to customers' homes, today announced expanded access to the new Zepbound® KwikPen® through Amazon Pharmacy. Eli Lilly's multi-dose injectable treatment for weight management is designed to deliver a full month of medication in a single device, offering patients a more convenient alternative by reducing the number of single-dose devices required. With a valid p...

OpenAI and Amazon Announce Strategic Partnership

SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)--OpenAI and Amazon (NASDAQ: AMZN) today announced a multi-year strategic partnership to accelerate AI innovation for enterprises, startups, and end consumers around the world. Amazon will also invest $50 billion in OpenAI, starting with an initial $15 billion investment and followed by another $35 billion in the coming months when certain conditions are met. Partnering to bring new advanced AI capabilities to enterprises worldwide OpenAI and Amazon are j...

Amazon Pharmacy Will Expand Same-Day Medication Delivery to Nearly 4,500 U.S. Cities and Towns by Year End

SEATTLE--(BUSINESS WIRE)--Amazon Pharmacy today announced it will expand its Same-Day prescription delivery service to nearly 4,500 U.S. cities and towns by the end of 2026—adding nearly 2,000 new communities over the course of the year. The expansion will bring fast, reliable medication delivery to millions of customers nationwide, including new states such as Idaho and Massachusetts, where pharmacy closures, staffing shortages, and transportation barriers have historically limited access to c...
Back to Newsroom